Sumithira Vasu, MBBSThe James Cancer Center
- Acute Myeloid Leukemias
- Anemia, Aplastic
- Blood Cancers
- Bone Marrow Transplantation
- Hemoglobinuria, Paroxysmal
- Myelodysplastic Syndromes
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Make an Appointment
I’m an oncologist treating patients with leukemia. I specialize in hematology with a specific focus on acute myeloid leukemias, myelodysplastic syndromes and bone marrow transplantation. Every day, my colleagues and I at the OSUCCC – James collaborate to create targeted therapies for each patient.
I serve as an assistant professor in Ohio State’s division of hematology. In addition to teaching, I participate in grant-funded research to better understand specific cancers. I focus on developing pharmacologic and immunologic therapies to pre-emptively manage cancer relapse following bone marrow transplantation.
Cancer is complex, but I’m confident our research continues to bring us closer to finding a cure. My work has been featured in medical publications, including Leukemia & Lymphoma, Bone Marrow Transplantation and Biology of Blood and Marrow Transplantation.
It’s an honor to work at one of the nation’s premier cancer hospitals. Our collective expertise results in faster responses, fewer side effects and more hope for cancer patients everywhere.
Education and Background
Thanjavur Medical College
Warren Magnuson Clinical Center
National Institute of Health - NHLBI
- American Board of Internal Medicine
- American Board of Internal Medicine (Subspecialty: Hematology)
- American Board of Pathology (Subspecialty: Blood Bank/Transfusion Medicine)
- Department of Internal Medicine
- Division of Hematology
I see patients at
The James Cancer Hospital and Solove Research Institute
460 West 10th Avenue, Columbus, Ohio 43210
Consulting and Related Relationships
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 3/28/2017, Dr. Vasu has reported no financial relationships with medical device, research and/or drug companies.